MyFinsight
Home
Blog
About
Comprehensive loss
-$46,954K
(18.76%↑ Y/Y)
Net loss
-$46,710K
(22.54%↑ Y/Y)
Total other
comprehensive (loss) income
-$244K
(-109.75%↓ Y/Y)
Net income (loss)
from discontinued...
$10,611K
Net loss from
continuing operations
-$57,321K
Unrealized (loss) gain on
available-for-sale securities
-$210K
Foreign currency
translation adjustment
-$34K
(-101.31%↓ Y/Y)
Interest income, net
$3,232K
(-46.87%↓ Y/Y)
Gain (loss) on
investments
$1,987K
(967.69%↑ Y/Y)
Other income
(expense), net
$809K
(190.29%↑ Y/Y)
Loss from continuing
operations before income...
-$57,193K
(5.60%↑ Y/Y)
Income tax (benefit)
expense
$128K
(145.23%↑ Y/Y)
Total other income
(expense)
$1,355K
(-72.67%↓ Y/Y)
Loss on equity method
investment
-$4,673K
Loss from operations
-$58,548K
(10.67%↑ Y/Y)
Revenue
$20,156K
(-59.37%↓ Y/Y)
Total operating
expenses
$78,704K
(-31.65%↓ Y/Y)
Research and development
$46,210K
(-13.42%↓ Y/Y)
General and
administrative
$30,775K
(-28.89%↓ Y/Y)
Cost of other revenue
$1,719K
Back
Back
Income Statement
Ginkgo Bioworks Holdings, Inc. (DNA)
Ginkgo Bioworks Holdings, Inc. (DNA)
source: myfinsight.com